GBS, Breaking the Stereotypes of Clinicians’ Minds: A Case Study of Atypical Presentation of GBS, Caused by COVID-19 Vaccination?
Published: 2022-09-22
Page: 160-166
Issue: 2022 - Volume 5 [Issue 1]
Rabia Arshad *
Department of Emergency and Critical Care (DEC), Holy Family Hospital, Rawalpindi, Pakistan.
Zoha Fatima
DEC, Holy Family Hospital, Pakistan.
Ujala Abdul Rashid
DEC, Holy Family Hospital, Pakistan.
Umara Nasim
DEC, Holy Family Hospital, Pakistan.
*Author to whom correspondence should be addressed.
Abstract
The clinicopathologic spectrum of Guillain Barré Syndrome (GBS) has expanded to include both inflammatory injuries that lead to demyelination and axonal loss forms that cause the motor and sensory loss. However, GBS may also have atypical presentations, that intrigue the clinicians’ interest. COVID-19 vaccines and their adverse effects are an emerging topic in medicine. While GBS has been reported as a rare complication of COVID-19 infection as well as after the meningococcus, influenza, polio, and rabies vaccine; a definitive association with the COVID-19 vaccine is yet to be established.
Keywords: Guillain Barré Syndrome (GBS), COVID-19, vaccine, pandemic